Satellos Prices $50 Million US Canada Public Offering to Fund Pipeline
Satellos has priced a US$50 million public offering of common shares in Canada and the United States at a fixed price per share. Net proceeds will support clinical pipeline advancement, general corporate purposes and potential business development initiatives.
1. Offering Announcement
Satellos announced the pricing of a public offering of common shares totaling US$50 million, offered concurrently in Canada and the United States. The offering is intended to strengthen the company’s balance sheet and provide funding for strategic priorities.
2. Use of Proceeds
Net proceeds from the offering are earmarked for advancing Satellos’ clinical development pipeline, supporting general corporate expenses and exploring potential business development opportunities to enhance long-term growth.
3. Market and Investor Impact
The share issuance may result in dilution for existing shareholders but is designed to extend Satellos’ cash runway and position the company to achieve key value-creating milestones in its research programs.